These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8742551)

  • 21. Dynamic systems-modeling as a means to estimate community-based prevention effects.
    Kibel BM; Holder HD
    NIDA Res Monogr; 1994; 142():404-46. PubMed ID: 9243542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Errors in assessing DSM-IV substance use disorders.
    Grant BF; Compton WM; Crowley TJ; Hasin DS; Helzer JE; Li TK; Rounsaville BJ; Volkow ND; Woody GE
    Arch Gen Psychiatry; 2007 Mar; 64(3):379-80; author reply 381-2. PubMed ID: 17339528
    [No Abstract]   [Full Text] [Related]  

  • 23. Regression to the mean in addiction research.
    Stout RL
    Addiction; 2008 Jan; 103(1):53. PubMed ID: 18081611
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessing effectiveness of drug abuse prevention: implementation issues relevant to long-term effects and replication.
    Hawkins JD; Abbott R; Catalano RF; Gillmore MR
    NIDA Res Monogr; 1991; 107():195-212. PubMed ID: 1922306
    [No Abstract]   [Full Text] [Related]  

  • 25. Consecutive treatments and the "random walk".
    Rinchuse DJ; Rinchuse DJ; Karam JR
    Am J Orthod Dentofacial Orthop; 2008 Jun; 133(6):792-5. PubMed ID: 18538240
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug use disorders in the National Comorbidity Survey: have we come a long way?
    Cottler LB
    Arch Gen Psychiatry; 2007 Mar; 64(3):380-1; author reply 381-2. PubMed ID: 17339529
    [No Abstract]   [Full Text] [Related]  

  • 27. Research design strategies to evaluate the impact of formulations on abuse liability.
    McColl S; Sellers EM
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S52-62. PubMed ID: 16554125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Universal school-based substance abuse prevention programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and marijuana use.
    Stephens PC; Sloboda Z; Stephens RC; Teasdale B; Grey SF; Hawthorne RD; Williams J
    Drug Alcohol Depend; 2009 Jun; 102(1-3):19-29. PubMed ID: 19362433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression to the mean in substance use disorder treatment research.
    Finney JW
    Addiction; 2008 Jan; 103(1):42-52. PubMed ID: 17999707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing and analyzing studies of onset, cessation, and relapse: using survival analysis in drug abuse prevention research.
    Singer JD; Willett JB
    NIDA Res Monogr; 1994; 142():196-263. PubMed ID: 9243538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodological issues in the assessment of substance use phenotypes.
    Neale MC; Aggen SH; Maes HH; Kubarych TS; Schmitt JE
    Addict Behav; 2006 Jun; 31(6):1010-34. PubMed ID: 16723188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.
    Kendler KS; Prescott CA; Myers J; Neale MC
    Arch Gen Psychiatry; 2003 Sep; 60(9):929-37. PubMed ID: 12963675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues in classification in meta-analysis in substance abuse prevention research.
    Hansen WB; Rose LA
    NIDA Res Monogr; 1997; 170():183-201. PubMed ID: 9154258
    [No Abstract]   [Full Text] [Related]  

  • 34. Substance abuse prevention intervention research with Hispanic populations.
    Castro FG; Barrera M; Pantin H; Martinez C; Felix-Ortiz M; Rios R; Lopez VA; Lopez C
    Drug Alcohol Depend; 2006 Sep; 84 Suppl 1():S29-42. PubMed ID: 16787713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experiments versus quasi-experiments: do they yield the same answer?
    Shadish WR; Heinsman DT
    NIDA Res Monogr; 1997; 170():147-64. PubMed ID: 9154256
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessing the most powerful analysis method for school-based intervention studies with alcohol, tobacco, and other drug outcomes.
    Janega JB; Murray DM; Varnell SP; Blitstein JL; Birnbaum AS; Lytle LA
    Addict Behav; 2004 May; 29(3):595-606. PubMed ID: 15050677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Let's keep in touch: you know it makes sense'.
    Orford J
    Addiction; 2009 Jun; 104(6):972-3. PubMed ID: 19466921
    [No Abstract]   [Full Text] [Related]  

  • 38. Meta-analytical issues for prevention intervention research.
    Tobler N
    NIDA Res Monogr; 1994; 142():342-403. PubMed ID: 9243541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical unresolved issue in transdisciplinary prevention research.
    Pentz MA
    Subst Use Misuse; 2004; 39(10-12):2079-80. PubMed ID: 15587962
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis with missing data in drug prevention research.
    Graham JW; Hofer SM; Piccinin AM
    NIDA Res Monogr; 1994; 142():13-63. PubMed ID: 9243532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.